article thumbnail

Potential breakthrough in treatment of urea associated skin diseases

Drug Discovery World

The active component of MC2-25 CKD is a di-peptide, which is formulated in cream based on MC2 Therapeutics’ formulation and drug delivery system PAD Technology. This new understanding of the role played by carbamylation in CKD-aP is very exciting and offers hope to millions of patients.”

article thumbnail

Skin Cancer Awareness Month 2024 and Insights from Medicus Pharma

XTalks

Companies specializing in dermatology and skincare have developed a range of products aimed at protecting the skin from harmful UV rays. In fact, tools such as dermatoscopes, digital imaging systems and artificial intelligence (AI)-powered diagnostic tools have become integral to dermatological practice.

article thumbnail

Next Generation Complement Therapeutics: Potential Life-Changing Therapies for Multiple Rare Disorders

Roots Analysis

Majority of these are biologics and are being developed for the treatment of different disease conditions, including dermatological, genetic, hematological and vascular, immunological and inflammatory, infectious, neurological, ophthalmic, renal disorders. Next Generation Complement Therapeutics. Broad Clinical Trial Landscape. Web: [link].